Pharmaceutical companies usually provide innovation that helps improve the lives of patients. But AstraZeneca marketed Nexium, a drug that should have never been approved in the first place. The ...

(Reuters) - The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such ...

Nexium Control is a once daily tablet that provides continuous 24 hour protection from heartburn and acid reflux. PBefore drugs are given or other potentially fatal procedures undertaken, it should ...

After nearly 15 years on the market, AstraZeneca’s popular “purple pill,” Nexium, will face generic competition. Teva Pharmaceuticals, an Israeli generics manufacturer with American headquarters in ...

For 9 months AstraZeneca ($AZN) has had the sales of its blockbuster heartburn drug Nexium protected by a bureaucratic dam that has kept generics from getting to ...

A US court has ruled that an alternative salt form of Nexium does not infringe on patents that protect AstraZeneca's version of the drug. This means that Hanmi Pharmaceutical's form of the proton pump ...